These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3287800)
41. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer. van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544 [TBL] [Abstract][Full Text] [Related]
42. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403 [TBL] [Abstract][Full Text] [Related]
43. How to integrate serum tumor markers into clinical oncologic practice. van Dalen A Nutrition; 1995; 11(5 Suppl):489-91. PubMed ID: 8748205 [TBL] [Abstract][Full Text] [Related]
44. [Tumor markers used in oncology]. Arce Vela R Rev Gastroenterol Peru; 1989; 9(2):100-5. PubMed ID: 2519234 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of human serum based tumor marker control. Chapman D; Fontana L J Nucl Med Allied Sci; 1989; 33(3 Suppl):114-7. PubMed ID: 2593008 [TBL] [Abstract][Full Text] [Related]
47. [Comparative immunoenzyme analysis of the fertility alpha2-microglobulin in healthy donors and in patients with gynecological malignancies]. Shcherbakova LA; Tatarinov IuS; Kalashnikov VV; Murashov VA; Olefirenko GO Vopr Med Khim; 1988; 34(5):23-5. PubMed ID: 2464236 [TBL] [Abstract][Full Text] [Related]
48. [Basic and clinical study of oncofetal antigen in the field of gynecology]. Nihon Sanka Fujinka Gakkai Zasshi; 1987 Aug; 39(8):1204-46. PubMed ID: 3451933 [No Abstract] [Full Text] [Related]
49. Role of tumor markers in patients with solid cancers: A critical review. Duffy MJ Eur J Intern Med; 2007 May; 18(3):175-84. PubMed ID: 17449388 [TBL] [Abstract][Full Text] [Related]